Shimomura Iwao, Miki Yoshihiro, Suzuki Eiko, Katsumata Mineo, Hashimoto Dai, Arai Yoshifumi, Otsuki Yoshiro, Nakamura Hidenori
Department of Pulmonary Medicine, Seirei Hamamatsu General Hospital, 430-0906 2-12-12, Sumiyoshi Naka-ku, Hamamatsu-city, Shizuoka, Japan.
Department of Respirology, Graduate School of Medicine, Chiba University, 260-8670 1-8-1, Inohana Chuo-ku, Chiba, Japan.
Respir Med Case Rep. 2018 Dec 8;26:101-104. doi: 10.1016/j.rmcr.2018.12.004. eCollection 2019.
A 61-year-old woman with a history of palpebral conjunctival mucosa-associated lymphoid tissue (MALT) lymphoma, treated with rituximab, was referred to the authors' hospital after follow-up positron emission tomography/computed tomography revealed F-fluoro-2-deoxy-d-glucose uptake in a tumor located in the left main bronchus. The diagnosis of MALT lymphoma was made by pathological and immunohistochemical findings homologous to previous palpebral conjunctival lesion via bronchoscopic biopsy. The disease was controlled with rituximab, cyclophosphamide, oncovin, and prednisolone (i.e., R-COP) chemotherapy. Although MALT lymphoma occurs in several organs, metachronous occurrence in the palpebral conjunctiva and bronchus is especially rare, and careful check-up is required to monitor for occurrence of systemic relapse.
一名61岁女性,有睑结膜黏膜相关淋巴组织(MALT)淋巴瘤病史,曾接受利妥昔单抗治疗。后续正电子发射断层扫描/计算机断层扫描显示左主支气管肿瘤有氟-2-脱氧-D-葡萄糖摄取后,她被转诊至作者所在医院。通过支气管镜活检,依据与先前睑结膜病变同源的病理和免疫组化结果确诊为MALT淋巴瘤。该疾病采用利妥昔单抗、环磷酰胺、长春新碱和泼尼松龙(即R-COP)化疗进行控制。尽管MALT淋巴瘤可发生于多个器官,但睑结膜和支气管异时发生极为罕见,需要仔细检查以监测全身复发情况。